Main Page


Jump to: navigation, search

TBI: Theragen BiO institute

TBI (Theragen BiO Institute) is the Genome Business Division of Theragen Inc. Korea.

TBI provides genome sequencing, analysis, and hardware/software box. Are you interested in joining us for realizing the genome revolution?

It is headed by Dr. Jong Bhak, CEO of TBI (The genomics division of TheragenEtex Inc.):




 TBI News
►TBI has a San Diego office (from 2013 Jan.)
Research: TBI is genomics/bioinformatics center

Personalized Medicine

Personal Genomics

AngioGenesis drug


RNA expression

Protein structure


Projects at TBI

♦  GenomeCare: TBI aims to link genes to diseases

♦  Korean Genome: The first Korean genome was analyzed by Theragen scientists.

♦  Asian Genome Diversity: PASNP

♦  Family Genome Sequencing: Theragen is working with LCDI and Samsung SDS to sequence 2 family genomes.

♦  Molecular Diagnosis



 Resources at TBI
Page logo 1.gif Classified 
Mol logo.png
Pic logo.png
User logo.png
 Theragen BiO researchers


  Jong Bhak

  SungHoon Lee



External links


 If you have any need for genomics and bioinformatics, please contact us. We provide world top level service for you.





Personal tools